Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease. a Retrospective and Prospective 20-year Follow-up.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02060565

Acronym

PVNIM

Enrollment

10000

Registered

2014-02-12

Start date

2014-02-28

Completion date

2034-02-28

Last updated

2023-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Liver Disease

Keywords

diagnosis, survival, non-invasive method, cirrhosis, FibroScan

Brief summary

The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.

Detailed description

All consecutive patients with chronic liver disease will be followed during 20 years.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* chronic hepatitis C * chronic hepatitis B * alcohol liver disease * non alcoholic liver disease

Exclusion criteria

* ascitis

Design outcomes

Primary

Measure	Time frame
Overall survival	20 years

Secondary

Measure	Time frame
Survival without liver complications	20 years

Other

Measure	Time frame
Survival without liver transplantation	20 years

Countries

France

Contacts

Primary ContactVictor de Lédinghen, MD, PhD

victor.deledinghen@chu-bordeaux.fr0033557656439

Backup ContactJuliette Foucher

juliette.foucher@chu-bordeaux.fr0033557656439

Outcome results